Account Manager - Cutaneous Oncology

Responsibilities

• Promote Odomzo and Unloxcyt to healthcare providers, including dermatologists, oncologists, and key decision-makers
• Educate customers on clinical data, product benefits, and differentiated mechanisms of action
• Execute territory business plans through strategic targeting and customer engagement tactics
• Navigate complex office and hospital-based pathways to support buy-and-bill, reimbursement, and access
• Collaborate with internal stakeholders including Market Access, Field Reimbursement Managers, and Medical Science Liaisons
• Track and analyze territory performance data to achieve sales goals
• Attend and support local and national conferences, speaker programs, and educational events

Requirements

• Bachelor’s degree
• Minimum 3 years of pharmaceutical, biotech, or medical device sales experience
• Demonstrated success in specialty sales, preferably in oncology or dermatology
• Strong understanding of reimbursement, specialty pharmacy, and infusion channel dynamics
• Ability to travel extensively within the assigned territory
• Excellent communication, negotiation, and presentation skills

Preferred Qualifications

• Experience launching new oncology or dermatology products
• Knowledge of Hedgehog Pathway Inhibitors and/or PD-L1 immunotherapies
• Existing relationships with dermatology oncologists or Mohs surgeons

Benefits

• Competitive base compensation ($135,000 to $175,000) plus IC Commission Plan
• Comprehensive medical, dental, and vision coverage
• 401(k) savings plan
• Life insurance and disability insurance
• Paid time off, including vacation and sick time
• Eligibility for company vehicle receipt

About the Company

Sun Pharma is a leading player in the pharmaceutical market, rapidly expanding its presence in the specialty branded market with a focus on dermatology, ophthalmology, and oncology. We foster an inclusive and collaborative work culture where employees are empowered to thrive through our core values of humility, integrity, passion, and innovation.